首页 | 本学科首页   官方微博 | 高级检索  
检索        


The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation
Authors:Arnon Broides  Amarilla B Mandola  Jacov Levy  Baruch Yerushalmi  Vered Pinsk  Michal Eldan  George Shubinsky  Nurit Hadad  Rachel Levy  Amit Nahum  Atar Lev  Amos Simon  Raz Somech
Institution:1.Pediatric Immunology Clinic, Soroka University Medical Center, Faculty of Health Science,Ben-Gurion University of the Negev. POB151,Beer Sheva,Israel;2.Soroka University Medical Center,Beer Sheva,Israel;3.Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer Sheva,Israel;4.Pediatric Ambulatory Care Unit, Soroka University Medical Center, Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer Sheva,Israel;5.Tel-Sheva Clinic, Clalit Health Services,Tel-Sheva,Israel;6.Flow Cytometry Unit, Hematology Laboratory, Soroka University Medical Center, Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer Sheva,Israel;7.Immunology and Infectious Disease Laboratory, Department of Clinical Biochemistry, Soroka University Medical Center, Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer Sheva,Israel;8.Pediatric Department A,Soroka University Medical Center,Beer Sheva,Israel;9.Pediatric Hemato-Oncology Department, Soroka University Medical Center, Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer Sheva,Israel;10.Pediatric Immunology, Safra Children’s Hospital, Sheba Medical Center,Tel Aviv University,Tel Hashomer,Israel;11.Sackler School of Medicine,Tel Aviv University,Tel Aviv,Israel
Abstract:Mutations in the dedicator of cytokinesis 8 (DOCK8) gene cause a combined immunodeficiency usually diagnosed as autosomal recessive hyper IgE syndrome. We sought to reveal the varying manifestations in patients with a unique mutation in DOCK8 gene by a retrospective medical record review. Ten patients from five consanguineous families and three tribes were included. Seven patients were homozygous for the c.C5134A, p.S1711X mutation, and the remaining three patients were their siblings manifesting hyper IgE syndrome features without a genetic diagnosis. Prior to the genetic diagnosis, the clinical diagnosis was “hyper IgE syndrome” in six patients and “anti-pneumococcal antibody deficiency,” “recurrent pneumonia with bronchiectasis,” and “asthma with hypereosinophilic syndrome” each diagnosed once. One additional patient was diagnosed due to family history. The age of presentation varied from 1 to 16 months. Eczema was diagnosed in all patients, food allergies in three, and severe herpes keratitis or malignancy or autoimmunity in two patients. Elevated IgE was recorded in nine patients; however, in six patients, the initial serum IgE concentration was equal to or less than three times the normal concentration for age, and in these patients, the median age at IgE evaluation was 7.5 months compared with 21.5 months in patients with an initial IgE concentration above three times the normal concentration for age (P = 0.067). The spectrum of disease manifestations in patients with a unique mutation in DOCK8 is variable. The genotype-phenotype correlations may be modified by genetic and/or epigenetic modifiers beyond the monogenic effect. Younger patients tend to have lower IgE concentrations at the initial measurement of IgE.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号